Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion
about
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewPatient's self-recognition of reduced visual acuity due to recurrence of macular edema and prompt visitation to the hospital in retinal vein occlusion.Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusionIntravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results.Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.Branch retinal vein occlusion: treatment modalities: an update of the literature.The ABCs of RVO: a review of retinal venous occlusion.Results of intravitreal triamcinolone acetonide in patients with macular edema secondary to branch retinal vein occlusion.Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion.Emerging roles for antiangiogenesis factors in management of ocular disease.Intravitreous bevacizumab treatment for macular edema due to central retinal vein occlusion.Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion.Bevacizumab and triamcinolone for branch vein occlusion.Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion: a Meta-analysis.Evaluation of pattern electroretinogram in retinal vein occlusion treated with intravitreal triamcinolone acetonide.
P2860
Q27013836-D977C78E-A644-4A0C-851E-3CD437256CD7Q33686686-C0CAD971-FB13-4D39-B564-FFD9D541DADEQ33771437-C1158CCD-5B98-4E60-BE04-F73C1856AD46Q33959122-7297AF09-9D7C-48CE-9014-DEA6DAFEED15Q34106112-B2C288AC-59C0-493B-8EE3-3F962C74B6B2Q35028773-D086DD26-2BAE-4A2C-BFF4-44F600B56DC1Q35047634-15D5F7D9-FBE5-4A30-BBB5-46403EBB4ED0Q35089534-986B800F-12DE-4945-BE04-0192C786F00DQ35098562-4934D336-DE6A-4084-BCD1-99A1D2C07709Q36696513-E48406CA-DA3B-4AEC-B3A4-CCDB711A6643Q38016231-FBDD37E6-7F44-4275-B259-453759421692Q42372246-20886035-A1DC-4A89-AF01-5DC6C24BDE16Q42758483-3C4F31FF-73F8-4D53-BE0C-7E86FAA3D017Q43165611-8DE7ED93-0641-4229-9CEE-0A9B6BEAFDE5Q53130341-164CF814-932F-4974-8B01-917DB4808F74
P2860
Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison between intravitrea ...... branch retinal vein occlusion
@en
Comparison between intravitrea ...... branch retinal vein occlusion.
@nl
type
label
Comparison between intravitrea ...... branch retinal vein occlusion
@en
Comparison between intravitrea ...... branch retinal vein occlusion.
@nl
prefLabel
Comparison between intravitrea ...... branch retinal vein occlusion
@en
Comparison between intravitrea ...... branch retinal vein occlusion.
@nl
P2860
P1476
Comparison between intravitrea ...... branch retinal vein occlusion
@en
P2093
Jin Young Kim
Sung Pyo Park
P2860
P304
P356
10.3341/KJO.2009.23.4.259
P577
2009-12-04T00:00:00Z